Summary
Carpentier-Edwards Perimount valves have a proven track record of low
reoperation rates in aortic valve replacement. The St. Jude Medical
Trifecta is a newer valve that has shown comparable outcomes. Given
midterm data for Trifecta is still sparse, we wanted to confirm the low
early reoperation rates of Trifecta persist over time. The reoperation
rates of Perimount and Trifecta were comparable, with Trifecta showing
higher rates in patients younger than 60 years, and current smokers.